Arno Therapeutics Board of Directors Appoints Randy Thurman as Vice Chairman
March 24, 2014 16:01 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J., March 24, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...
Arno Therapeutics to Present at 26th Annual ROTH Conference
March 05, 2014 08:45 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J., March 5, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...
Arno Therapeutics Granted Exclusive License for Oncology Diagnostic Technique by University of Minnesota
March 04, 2014 08:31 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J., March 4, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...
Arno Therapeutics Appoints Lawrence A. Kenyon Chief Financial Officer
February 27, 2014 10:00 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...
Arno Therapeutics Enrolls First Patient in a Phase I Trial to Evaluate Lead Compound Onapristone in Progesterone Receptor Positive Solid Tumors
January 21, 2014 12:06 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J., Jan. 21, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
January 13, 2014 08:15 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J., Jan. 13, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today...
Arno Therapeutics to Present at Biotech Showcase 2014
January 09, 2014 08:30 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J., Jan. 9, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced...
Arno Therapeutics Selects Leica Biosystems to Develop Companion Diagnostic for Targeted Oncology Therapy Onapristone
January 07, 2014 08:15 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J. and NEWCASTLE UPON TYNE, England, Jan. 7, 2014 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI); (Arno), a clinical stage biopharmaceutical company focused on the development...
Arno Therapeutics to Present Data on Two Potential Predictive Biomarkers at the San Antonio Breast Cancer Symposium 2013
December 14, 2013 08:30 ET
|
Arno Therapeutics Inc.
- Data Expand Support for Development of Diagnostic to Identify Patients With Biomarkers of Anti-Progestin and Anti-Estrogen Activity -
- Bolster Findings Presented at ASCO and ECC 2013...
Arno Therapeutics Adds Steven Rubin, EVP of OPKO Health, Inc., as Board Observer
November 18, 2013 09:27 ET
|
Arno Therapeutics Inc.
FLEMINGTON, N.J., Nov. 18, 2013 (GLOBE NEWSWIRE) -- Arno Therapeutics, Inc. (OTCQB:ARNI), a clinical stage biopharmaceutical company focused on the development of targeted oncology therapeutics, today...